Short Interest in Oxford Biomedica plc (OTCMKTS:OXBDF) Rises By 2,500.0%

Oxford Biomedica plc (OTCMKTS:OXBDF) was the target of a significant growth in short interest in October. As of October 31st, there was short interest totalling 2,600 shares, a growth of 2,500.0% from the October 15th total of 100 shares. Based on an average trading volume of 700 shares, the short-interest ratio is currently 3.7 days.

Oxford Biomedica Stock Up 6.1 %

OTCMKTS:OXBDF traded up $0.31 during trading hours on Thursday, reaching $5.41. 4,750 shares of the company’s stock were exchanged, compared to its average volume of 6,415. The business’s 50-day simple moving average is $4.96 and its two-hundred day simple moving average is $4.46. The company has a current ratio of 2.35, a quick ratio of 2.07 and a debt-to-equity ratio of 1.48. Oxford Biomedica has a 12 month low of $2.09 and a 12 month high of $5.68.

About Oxford Biomedica

Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its s LentiVector platform technology is an advanced lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems.